Skip to content
Open menu

Gynaecological magnetic resonance imaging treatments in cancer care

At Docrates Cancer Center magnetic resonance imaging is offered to give information about the extent and the spread of gynaecological cancer. Imaging is also used when planning individual cancer care. Our imaging specialists and our newest three-tesla scanner enables more specific diagnosis and more tailored treatment plans. Docrates Cancer Center offers quick access to state-of-the art imaging equipment.

Magnetic resonance imaging can be utilized within cancer diagnostics and also in follow-up of cancer treatment results and if local reocurrance is suspected. Then magnetic resonance imaging is complementing other imaging or can verify local and spread metastases.

Magnetic resonance imaging can be used in many gynaecological areas due to its good detection of different soft tissues. With magnetic resonance imaging it is possible to detect deviant tissues for example in cervical and uterus cancer and also in cancer in vagina and genitals. With magnetic resonance imaging of ovaries for example benign changes from malign ones can be spotted. Also more precise timing of contrast agent is aiming at more exact definition of abnormal changes.

Magnetic resonance imaging is especially used in benign changes in endometeriosis as the deep metastases may be detected only with magnetic resonance imaging.

At Docrates Cancer Center we have expertise within imaging treatments of gynaecological cancers. Our radiology specialist Johanna Virtanen is an expert of gynaecological cancer imaging among others.

At Docrates, MRI scans are performed using the newest three-tesla scanner by Siemens, Magnetom Vida 3T. It produces scans using a three-tesla magnetic field. This enables us to make even more specific diagnoses, and as a result, create better and more individually tailored treatment plans.

 

 

 

Read more

Chief Clinical Director of Docrates Cancer Center: “Genetic information is an essential part of modern cancer care”

New forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...

Read more

Customer message 3. September, 2024

With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...

The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center

On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....

Breast reconstruction aims for a great quality of life — the new breast is usually made from the patient’s own tissue

Breast cancer is a serious disease that requires individual care and expertise. As part of cancer treatment, the patient may...

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00